In a landmark agreement that underscores the surging therapeutic potential of proximity biology, Swiss pharmaceutical giant Roche has joined forces…
Read More
WuXi XDC and Ona Therapeutics Expand Partnership Through Exclusive Global Licensing Agreement for Advanced Antibody-Drug Conjugate Platform
In a significant expansion of their ongoing strategic partnership, WuXi XDC Cayman has entered into an exclusive global licensing agreement…
Read More
Novo Secures $1.4bn Partnership With Orbis Medicines to Bolster Cardiometabolic Pipeline Through AI-Driven Macrocycle Therapeutics
In a strategic move to fortify its cardiovascular and metabolic disease pipeline following a sequence of high-profile clinical and commercial…
Read More
Eli Lilly and Partner QurCan Therapeutics Form Strategic Alliance to Advance Next-Generation Genetic Medicines for Nervous System Disorders
The landscape of genetic medicine took a significant stride forward as pharmaceutical giant Eli Lilly and Company joined forces with…
Read More
Cellares and GenomeFrontier Therapeutics Partner to Automate Virus-Free CAR-T Cell Therapy Manufacturing on the Cell Shuttle Platform
The global cell therapy landscape is undergoing a profound structural shift as biotechnology innovators increasingly look toward end-to-end automation to…
Read More
Sling Therapeutics Secures $123M in Series C Financing to Advance Pivotal Phase III Trial of First-in-Class Oral TED Treatment
Sling Therapeutics has closed a significant $123 million Series C financing round, directing the capital toward the pivotal late-stage clinical…
Read More
New Protein Discovery Unveils Critical Mechanism in Bone Remodeling and Offers Promising Pathway for Osteoporosis Therapeutics
Bone health remains a foundational pillar of human mobility, structural integrity, and overall physiological wellness. Throughout a human lifetime, the…
Read More
Exegenesis Bio and Modalis Therapeutics Join Forces in Strategic Licensing Agreement to Advance MDL-201 Gene Therapy for Duchenne Muscular Dystrophy
In a significant development for the field of genetic medicine, biotechnology innovators Exegenesis Bio and Modalis Therapeutics have formally announced…
Read More
Encoded Therapeutics Secures $275M in Series F Financing to Advance Groundbreaking Gene Therapy for Dravet Syndrome and Expand Clinical Pipeline
Encoded Therapeutics has officially closed a massive $275 million Series F financing round, marking a critical financial milestone for the…
Read More
Affinia Therapeutics Secures FDA Orphan Drug Designation for AFTX-201, a Promising Gene Therapy for BAG3-Associated Dilated Cardiomyopathy
Affinia Therapeutics has announced a significant milestone in the development of its investigational gene therapy, AFTX-201, with the US Food…
Read More
